We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$58.7B
AUM Growth
+$5.6B
(+11%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
15.44%
Holding
2,547
New
225
Increased
1,201
Reduced
957
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$150M |
| 2 |
GoDaddy
GDDY
|
+$129M |
| 3 |
Wynn Resorts
WYNN
|
+$106M |
| 4 |
Assurant
AIZ
|
+$104M |
| 5 |
Centene
CNC
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$672M |
| 2 |
Amgen
AMGN
|
+$200M |
| 3 |
Walmart Inc
WMT
|
+$150M |
| 4 |
Super Micro Computer
SMCI
|
+$141M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Financials | 13.49% |
| 3 | Consumer Discretionary | 13.4% |
| 4 | Healthcare | 13.12% |
| 5 | Industrials | 12.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Pulse Biosciences
PLSE
$3.17B
| $113K | ﹤0.01% |
+12,961
| New | +$119K |
|
|
NOTV
2327
DELISTED
Inotiv
NOTV
| $112K | ﹤0.01% |
10,254
-133,914
| -93% | -$800K |
|
2328
Archer Aviation
ACHR
$5.18B
| $111K | ﹤0.01% |
24,118
-14,024
| -37% | -$70.4K |
|
2329
Vanda Pharmaceuticals
VNDA
$298M
| $111K | ﹤0.01% |
26,944
+10,699
| +66% | +$42.8K |
|
2330
Invesco Mortgage Capital
IVR
$802M
| $109K | ﹤0.01% |
+11,266
| New | +$101K |
|
2331
Heron Therapeutics
HRTX
$61.3M
| $108K | ﹤0.01% |
38,897
+2,042
| +6% | +$5.13K |
|
2332
Ocular Therapeutix
OCUL
$2.14B
| $107K | ﹤0.01% |
11,755
-40,473
| -77% | -$287K |
|
2333
EverCommerce
EVCM
$1.75B
| $106K | ﹤0.01% |
11,242
-60,160
| -84% | -$587K |
|
2334
Savara
SVRA
$1.14B
| $106K | ﹤0.01% |
21,192
+5,491
| +35% | +$26.5K |
|
2335
Bit Digital
BTBT
$471M
| $104K | ﹤0.01% |
36,378
+460
| +1% | +$1.27K |
|
2336
Viavi Solutions
VIAV
$9.47B
| $103K | ﹤0.01% |
11,288
-19,791
| -64% | -$194K |
|
2337
CorMedix
CRMD
$573M
| $101K | ﹤0.01% |
23,830
-11,524
| -33% | -$40K |
|
2338
ImmunityBio
IBRX
$8.05B
| $101K | ﹤0.01% |
+18,725
| New | +$84.8K |
|
|
CNSL
2339
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $99.1K | ﹤0.01% |
+22,943
| New | +$99.8K |
|
2340
Tenaya Therapeutics
TNYA
$168M
| $98.9K | ﹤0.01% |
18,914
-4,480
| -19% | -$21.4K |
|
2341
Lyell Immunopharma
LYEL
$365M
| $98.7K | ﹤0.01% |
2,212
+700
| +46% | +$30K |
|
|
ME
2342
DELISTED
23andMe Holding Co
ME
| $96.2K | ﹤0.01% |
9,038
+8,270
| +1,077% | +$106K |
|
|
TEF
2343
DELISTED
Telefonica
TEF
| $95.7K | ﹤0.01% |
+21,694
| New | +$89.1K |
|
2344
Anavex Life Sciences
AVXL
$325M
| $93.6K | ﹤0.01% |
18,398
-203
| -1% | -$1.14K |
|
|
FRGE
2345
DELISTED
Forge Global Holdings
FRGE
| $93.6K | ﹤0.01% |
+3,234
| New | +$101K |
|
|
CTLP
2346
DELISTED
Cantaloupe
CTLP
| $93.2K | ﹤0.01% |
14,492
-93,918
| -87% | -$619K |
|
2347
Under Armour Class C
UA
$2.23B
| $93.1K | ﹤0.01% |
13,042
-16,813
| -56% | -$129K |
|
2348
Gevo
GEVO
$403M
| $90.9K | ﹤0.01% |
+118,292
| New | +$103K |
|
2349
Aegon
AEG
$13.9B
| $88.6K | ﹤0.01% |
+14,647
| New | +$85.3K |
|
2350
Frontier Group Holdings
ULCC
$1.59B
| $88.1K | ﹤0.01% |
+10,858
| New | +$70.3K |
|
Similar funds
VGA
AQR Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, AQR Capital Management held 2,547 positions worth $58.7B, up 11% from $53.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q1 2024 filing shows 225 new, 1,201 increased, 957 reduced and 144 closed positions. Its largest new stake was Snap: 4,386,413 shares worth $50.4M. The largest sale was TSMC, an estimated $672M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
- AQR Capital Management's largest Q1 2024 buy was Snap: 4,386,413 shares worth $50.4M.
- AQR Capital Management added most to Zoom in Q1 2024, an estimated $150M increase.
- AQR Capital Management's biggest Q1 2024 reduction was TSMC, cutting an estimated $672M.
- AQR Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $9.79M.
- AQR Capital Management's ten largest holdings make up 15% of its $58.7B portfolio in Q1 2024.
- AQR Capital Management opened 225 new positions and closed 144 in Q1 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $58.7B.
Based on AQR Capital Management's 13F filing for Q1 2024, filed 15 May 2024.